Joerg Heidrich, Sr. Vice President, Product Supply Biotech, Berkeley Site Head
A recognized leader in the field of biomanufacturing and a Bayer veteran, Mr.
Heidrich has dedicated more than 20 years of his professional career to the
management of various manufacturing operations within the global Bayer Group. He
currently heads the Global Biotechnology Product Supply organization overseeing
the manufacturing and distribution of Bayer’s $3 billion biotechnology product
portfolio.
His career at Bayer began as a project leader in 1986. Mr. Heidrich’s leadership
and knowledge in the areas of engineering and product development brought him to
manufacturing sites in East and West Germany, Mexico and beginning of 2001 to
Berkeley, California. Here he served as the VP of Production for Kogenate ®
at Bayer HealthCare until 2006, when he assumed the role as Senior Vice
President of Product Supply Biotech worldwide.
Olivia Krampe, Ph.D., Vice President, Supply Center Emeryville Site Head
A strong leader recognized for her team building abilities, Olivia Krampe is
responsible for all of the site operations at Supply Center Emeryville, a site
which was acquired by Bayer in 2007. As the site's key leader, Ms. Krampe
oversees all functions, including manufacturing, quality assurance and
engineering at the Emeryville site. Prior to arriving in the Bay Area, Ms.
Krampe was a part of the Schering organization for more than 15 years,
overseeing the manufacturing of some of the company's top products before
Schering was acquired by Bayer. In addition, she has more than 10 years
experience in leading manufacturing organizations covering API and
pharmaceutical manufacturing.
Ms. Krampe earned her Ph.D. in Chemistry at Technical University Aachen, Germany,
graduating summa cum laude.
Terry Hermiston, Ph.D., Vice President, Biologics Research, U.S. Innovation
Center Site Head
Dr. Hermiston leads the US biologics research team at Bayer HealthCare
Pharmaceutical’s world-wide pharmaceutical research organization. In addition,
he oversees the operation of Bayer’s West Coast research center.
With a biotechnology career spanning nearly two decades, Dr. Hermiston has
published nearly 40 research papers, holds four patents and has additional
patents pending. Prior to joining Bayer HealthCare Pharmaceuticals, Dr.
Hermiston was the principal scientist and scientific director for the global
department of gene therapy research and gene technologies for Berlex Biosciences
and its Germany-based parent company. Dr. Hermiston also served in roles of
increasing responsibility with Onyx Pharmaceuticals and completed a National
Institutes of Health (NIH) fellowship in microbiology and immunology at St.
Louis University School of Medicine.
